{"id":248974,"date":"2018-08-02T05:07:02","date_gmt":"2018-08-02T05:07:02","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=248974"},"modified":"2018-08-02T05:07:02","modified_gmt":"2018-08-02T05:07:02","slug":"heart-failure-drugs-2018-global-market-challenge-driver-trends-forecast-to-2023","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/heart-failure-drugs-2018-global-market-challenge-driver-trends-forecast-to-2023_248974.html","title":{"rendered":"Heart Failure Drugs 2018 Global Market Challenge, Driver, Trends &#038; Forecast to 2023"},"content":{"rendered":"<div style=\"font-style:italic; padding:8px 0px;\">Pune, India, 2nd August 2018: WiseGuyReports announced addition of new report, titled \u201c&#8221;Global Heart Failure Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023\u201d.\t\t<\/div>\n<p>In this report, the global <strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/reports\/3298163-global-heart-failure-drugs-market-by-manufacturers-regions\">Heart Failure Drugs<\/a><\/strong> market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2023, growing at a CAGR of XX% between 2017 and 2023.Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Heart Failure Drugs in these regions, from 2012 to 2023 (forecast), covering<\/p>\n<p>North America (United States, Canada and Mexico)<\/p>\n<p>Europe (Germany, France, UK, Russia and Italy)<\/p>\n<p>Asia-Pacific (China, Japan, Korea, India and Southeast Asia)<\/p>\n<p>South America (Brazil, Argentina, Columbia)<\/p>\n<p>Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)<\/p>\n<p>Global Heart Failure Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including<\/p>\n<p>Pfizer<\/p>\n<p>Novartis<\/p>\n<p>Merck<\/p>\n<p>Sanofi<\/p>\n<p>Johnson &amp; Johnson<\/p>\n<p>AstraZeneca<\/p>\n<p>GlaxoSmithKline<\/p>\n<p>Amgen<\/p>\n<p>Bayer<\/p>\n<p>BMS<\/p>\n<p>Cardiorentis<\/p>\n<p>Cytokinetics<\/p>\n<p>Ono Pharmaceuticals<\/p>\n<p>Mylan<\/p>\n<p>NCPC<\/p>\n<p>On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into<\/p>\n<p>Injection<\/p>\n<p>Capsule<\/p>\n<p>Tablets<\/p>\n<p>On the basis on the end users\/applications, this report focuses on the status and outlook for major applications\/end users, consumption (sales), market share and growth rate of Heart Failure Drugs for each application, including<\/p>\n<p>Hospital Pharmacies<\/p>\n<p>Retail Pharmacies<\/p>\n<p>Online Pharmacies<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Table of Content: Key Points<\/strong><\/p>\n<p>1 Market Overview<\/p>\n<p>2 Industrial Chain Analysis<\/p>\n<p>3 Global Heart Failure Drugs Players Profiles and Sales Data<\/p>\n<p>4 Global Heart Failure Drugs Market Competition by Manufacturers<\/p>\n<p>5 Global Heart Failure Drugs Market Analysis by Regions<\/p>\n<p>6 North America Heart Failure Drugs by Countries<\/p>\n<p>7 Europe Heart Failure Drugs by Countries<\/p>\n<p>8 Asia-Pacific Heart Failure Drugs by Countries<\/p>\n<p>9 South America Heart Failure Drugs by Countries<\/p>\n<p>10 Middle East and Africa Heart Failure Drugs by Countries<\/p>\n<p>11 Global Heart Failure Drugs Market Segment by Type<\/p>\n<p><strong>&hellip;Continued&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/strong><\/p>\n<p><strong>&nbsp;<\/strong><\/p>\n<p><strong><em>ACCESS REPORT @ <\/em><\/strong><a rel=\"nofollow\" href=\"https:\/\/www.wiseguyreports.com\/reports\/3298163-global-heart-failure-drugs-market-by-manufacturers-regions\"><strong><em>https:\/\/www.wiseguyreports.com\/reports\/3298163-global-heart-failure-drugs-market-by-manufacturers-regions<\/em><\/strong><\/a><strong><em> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/em><\/strong><\/p>\n<p><strong><em>&nbsp;<\/em><\/strong><strong>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;<\/strong><\/p>\n<p><strong>Get in touch:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/strong><\/p>\n<p><strong>LinkedIn: <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.linkedin.com\/company\/4828928?trk=tyah&amp;trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A4828928%2Cidx%3A2-1-6%2CtarId%3A1474885586759%2Ctas%3Awiseguy\"><strong>www.linkedin.com\/company\/4828928<\/strong><\/a><\/p>\n<p><strong>Twitter: <\/strong><a rel=\"nofollow\" href=\"https:\/\/twitter.com\/WiseGuyReports\"><strong>https:\/\/twitter.com\/WiseGuyReports<\/strong><\/a><strong> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/strong><\/p>\n<p><strong>Facebook: <\/strong><strong>https:\/\/www.facebook.com\/Wiseguyreports-1009007869213183\/?fref=ts<\/strong><strong>&nbsp;&nbsp;&nbsp;&nbsp; <\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Wiseguyreports.com<br \/><strong>Contact Person:<\/strong> Norah Trent<br \/><strong>Email:<\/strong> <a href='http:\/\/www.universalpressrelease.com\/?pr=heart-failure-drugs-2018-global-market-challenge-driver-trends-forecast-to-2023&#038;type=pra'>Send Email<\/a><br \/><strong>Phone:<\/strong> +1 646 845 9349, +44 208 133 9349<br \/><strong>City:<\/strong> Pune<br \/><strong>State:<\/strong> Maharashtra<br \/><strong>Country:<\/strong> India<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.wiseguyreports.com\" target=\"_blank\" rel=\"nofollow\">www.wiseguyreports.com<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.wiseguyreports.com\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"http:\/\/www.abnewswire.com\/press_stat.php?pr=heart-failure-drugs-2018-global-market-challenge-driver-trends-forecast-to-2023\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pune, India, 2nd August 2018: WiseGuyReports announced addition of new report, titled \u201c&#8221;Global Heart Failure Drugs Market by Manufacturers, Regions, Type and Application, Forecast to 2023\u201d. In this report, the global Heart Failure Drugs market is valued at USD XX &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/heart-failure-drugs-2018-global-market-challenge-driver-trends-forecast-to-2023_248974.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-248974","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/248974","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=248974"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/248974\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=248974"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=248974"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=248974"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}